
Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Policy
On October 4, 2023, Paula Chatterjee, MD, MPH, the LDI Director of Health Equity Research testified in front of the Pennsylvania House of Representatives Subcommittee on Health Facilities about the unprecedented market-level changes that have occurred in health care over the past decade, and the latest new hospital payment models designed to address the consequences of those changes. Her remarks focused on federal and state programs designed to to support financially stressed hospitals, particularly those in rural areas.
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Research Memo: Response to Request for Technical Assistance
Research Memo: Supplement to Response to Request for Technical Assistance
Research Memo: Delivered to Staff of U.S. Senate Committee on Finance